Cholesterol management after a recent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how well cholesterol-lowering treatments work after a recent stroke or mini-stroke. The goal is to see if optimizing cholesterol levels can help prevent future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke or a mini-stroke (TIA) less than 30 days ago.
- Your doctor has checked your cholesterol levels (LDL) recently.
- Your doctor has already prescribed cholesterol-lowering medication or a low-fat diet to prevent future events.
- You can give consent to join the study, either personally or through a legal representative.
- You are able to attend a follow-up visit about 3 months after the start of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different LDL cholesterol targets after a small vessel stroke to find the best level for preventing another stroke. If you've had this type of stroke, you may be able to help doctors decide the right treatment goal.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This trial compares two treatments for people who recently had a stroke or TIA and have high cholesterol with artery plaque. Some participants will get a combination of two cholesterol-lowering medicines (statin and ezetimibe), while others will get only a statin.
This trial tests whether a cholesterol-lowering drug (called a PCSK9 inhibitor) can help people who had a stroke and a procedure to clear a blocked vessel. It aims to see if the drug reduces the risk of another stroke or improves recovery.
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
This trial tests whether adding an intensive cholesterol-lowering drug (called a PCSK9 inhibitor) to standard care can reduce the risk of another stroke or heart attack in people who recently had a stroke from narrowed brain or neck arteries. It is a high-dose approach designed to rapidly lower cholesterol and may offer extra protection for those with high Lp(a).
Hear when a new Stroke (CVA) or Transient Ischemic Attack trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.